Calcium+Company Boosts Leadership with New Appointments
Strategic Appointments at Calcium+Company
Calcium+Company, a prominent health communications firm, has recently made significant changes within its executive team. The company is pleased to announce that James Pietz has joined as the Managing Director of its oncology division, Amino. Meanwhile, Josh Righter has been elevated to the position of Chief Strategy Officer. Both leaders will report directly to Greg Lewis, Group President and Managing Partner.
Growth and Commitment through Leadership
This expansion of leadership reflects Calcium+Company's commitment to growth, particularly in vital sectors such as oncology. By enhancing its strategic capabilities, the company is poised to create a more substantial impact on the market, benefiting clients and their brands.
Focus on Client Needs
CEO Judy Capano emphasizes an unwavering focus on client value drivers, especially in crucial areas like oncology and omnichannel engagement. She states, "We are concentrating on what truly matters to our clients, and this is just the beginning." This dedication is central to the company's mission and vision moving forward.
James Pietz's Vision for Amino
As the new Managing Director, Pietz aims to broaden Amino's scope, introducing a more extensive range of cancer types, therapy classes, and client partnerships. His enhanced framework will capitalize on the established groundwork laid by Amino in the realms of precision insights and engaging storytelling. Pietz is set to lead the charge in crafting targeted engagements that speak directly to patient needs.
The Impact on Patients
Greg Lewis highlights the transformative potential of Pietz’s expertise within the oncology sector, stating, "James's deep knowledge will enable us to touch the lives of many more cancer patients, which drives our mission forward. This impact is a fundamental motivation for all of us here at Calcium+Company." Such commitment underscores the company's purpose to improve patient outcomes through strategic marketing initiatives.
Josh Righter's Strategic Role
In his new capacity as Chief Strategy Officer, Righter is tasked with enhancing the agency's suite of strategic services. His vision encompasses aligning market intelligence with brand planning and marketing communications, fostering a cohesive strategic vision that boosts efficacy and operational efficiency.
Mentoring Future Leaders
Lewis describes Righter as a visionary thinker who inspires those around him, stating, "He will now have the opportunity to spread his talents across various clients and divisions while cultivating the next generation of strategic leaders." This mentorship approach not only elevates current projects but also ensures a pipeline of skilled professionals for the future.
Innovative Marketing Initiatives
Moving forward, Righter will collaborate with Leigh Householder to spearhead the company’s Marketing and Innovation hub. This department is essential in delivering advanced, omnichannel solutions that leverage technology, data, and artificial intelligence for clients at Calcium+Company.
Acknowledging Excellence
Calcium+Company is known for its dedication to excellence and innovation in the healthcare marketing sphere. With a diverse team of over 175 employees spread across various locations, including New York and Philadelphia, the firm excels in strategic, scientific, and creative capabilities. Their recognition as one of the "MM+M Best Places to Work" in a recent year is a testament to their positive workplace culture.
Conclusion: The Future is Bright
The strategic changes happening at Calcium+Company mark an exhilarating chapter for the firm. With new leadership like James Pietz and Josh Righter, the company is well-equipped to navigate the complexities of healthcare marketing, particularly in oncology. This proactive approach is essential as the industry continues to evolve, enabling the company to address diverse patient needs effectively.
Frequently Asked Questions
Who is the new Managing Director of Calcium+Company?
The new Managing Director of Calcium+Company's oncology division, Amino, is James Pietz.
What is Josh Righter's new position at Calcium+Company?
Josh Righter has been promoted to Chief Strategy Officer.
What is the focus of Calcium+Company's growth strategy?
The growth strategy focuses on enhancing services in oncology and improving client engagement through strategic innovation.
What is the mission of Calcium+Company?
The mission is to deliver nourishment in all its forms to clients, brands, communities, and individuals.
How does Calcium+Company support its employees?
Calcium+Company is recognized for offering a positive workplace environment, which has earned it accolades such as being named a top place to work in the industry.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
